Pathology Re-Review in China: Slides, Tissue Blocks, Biomarkers, and What Hospitals May Request
Quick Answer
For an international cancer patient seeking a review in China, a pathology report may not be enough. The receiving hospital may ask for glass slides, a paraffin block, unstained slides, digital whole-slide images, biomarker results, or additional testing. The exact request depends on the diagnosis and the question being reviewed.
Digital pathology can sometimes begin the conversation before physical materials arrive, but it does not automatically replace the original slides or tissue. Before sending anything, confirm the required material, submission route, customs and courier rules, and return arrangements with both the original pathology department and the receiving hospital.
Key Takeaways
- A pathology report, glass slide, paraffin block, and digital slide are different things.
- The receiving hospital should specify what it needs.
- Digital whole-slide imaging may support preliminary review through an accepted institutional route.
- Physical material may still be needed for recutting, staining, molecular testing, or final confirmation.
- Tissue and pathology materials should not be treated like ordinary luggage or parcels.
Why can pathology re-review matter?
Treatment decisions are built on the diagnosis. When the cancer is rare, complex, recurrent, or linked to a biomarker-defined pathway, another pathology team may need to review the evidence behind the original report.
The purpose is not to assume the first report is wrong. It is to answer a specific question: Is the diagnosis sufficiently clear for the next treatment decision, and is the available tissue suitable for any additional testing?
Report, slide, block, digital image, or new sample?
| Material | What it is | What it may help another team do |
|---|---|---|
| Pathology report | Written interpretation of the specimen | Understand the original diagnosis, specimen site, stains, and findings |
| Glass slide | A thin prepared tissue section | Review morphology and existing stains |
| Paraffin block | Preserved tissue embedded in wax | Cut new sections or perform additional tests when material is sufficient |
| Unstained slide | Tissue section without a completed stain | Perform requested immunohistochemistry or other testing |
| Digital whole-slide image (WSI) | High-resolution scan of a glass slide | Support remote or preliminary pathology review through a compatible workflow |
| New biopsy or sample | Newly collected tissue | Considered by the clinical team when existing material does not answer the current question |
A new biopsy is a medical decision, not an administrative requirement. It may be discussed when existing tissue is inadequate, exhausted, non-representative, or no longer clinically useful.
When may a China hospital request re-review?
Common reasons include:
- a rare or difficult diagnosis
- conflicting pathology reports
- recurrence after prior treatment
- a biomarker-dependent treatment question
- insufficient information in the original report
- a need for additional immunohistochemistry or molecular testing
- an MDT that requires pathology confirmation before discussing the next step
Fudan University Shanghai Cancer Center publishes pathology consultation instructions that request original slides and the corresponding report, with additional materials depending on the case. Sun Yat-sen University Cancer Center also publishes requirements for slides or blocks and notes that additional testing can extend the review process.
These are hospital examples, not a universal China checklist.
Can digital pathology replace shipping slides or tissue?
Sometimes digital whole-slide imaging can support an earlier review. China has established institutional remote-pathology infrastructure, and official workflows describe scanning slides, uploading WSI files with clinical information, expert review, and return of a consultation report.
But these routes are commonly institution-led. An overseas patient should not assume that a hospital has an open consumer upload portal.
Digital WSI may help when:
- the original hospital can produce diagnostic-quality scans
- the receiving hospital accepts the format and submission channel
- the purpose is preliminary or remote review
- the pathology report and clinical context are included
Physical slides or blocks may still be needed when:
- scan quality is insufficient
- new sections, stains, or molecular tests are required
- the receiving hospital has no compatible digital route
- material identity, custody, or archiving requirements apply
The practical approach is to ask both pathology departments what can be done digitally and what must still move physically.
What should you ask the original pathology department?
Ask early. Pathology materials may be controlled archive items and can require formal borrowing and return.
Use this checklist:
- Can you provide the pathology report and original accession number?
- Are the original slides available for consultation?
- Is a paraffin block or a set of unstained slides available?
- Can the department create a diagnostic-quality WSI?
- Which file format is used, and how can it be transferred securely?
- What loan form or patient authorization is required?
- Which materials must be returned?
- Could any material be consumed by additional testing?
- How long will preparation take?
- Can an inventory be issued for everything released?
Keep the original labels and identifiers traceable. Do not rename files or remove identifiers unless the receiving institution instructs you to do so.
Can pathology material be carried or couriered to China?
Human tissue and related biological materials are regulated. China Customs treats these as controlled special items, and the origin country may also impose export requirements.
There is no safe universal rule that a patient can place slides or paraffin blocks in hand luggage or send them by an ordinary courier.
Before dispatch:
- Ask the receiving hospital exactly what it will accept.
- Ask the original pathology department what it can release.
- Confirm export and import requirements.
- Use a courier experienced with medical specimens if physical transfer is approved.
- Confirm packaging, documentation, temperature, tracking, and return arrangements.
- Do not ship until the receiving department confirms the destination and contact person.
What should accompany the material?
Prepare:
- original pathology report
- specimen date and anatomical site
- pathology accession or case number
- slide and block inventory
- list of stains already completed
- biomarker and molecular test results
- surgery or biopsy record
- relevant imaging and clinical summary
- prior treatment history
- translated summary if requested
- the specific question for re-review
DICOM is an imaging format used for radiology. It is not a substitute for pathology slides or WSI.
Biomarkers and advanced-treatment matching
Some oncology pathways depend on a defined biomarker or target expression. The receiving team may need to confirm the test method, sample quality, result, and whether the material still represents the current disease.
A positive biomarker result can open a clinical discussion. It does not by itself establish treatment eligibility or expected benefit.
How CareNavigator helps
CareNavigator helps families identify what the receiving China team is actually asking for, coordinate questions between institutions, prepare a traceable material checklist, and connect the pathology review to the wider hospital and treatment comparison.
We do not interpret pathology or decide whether a new biopsy is needed. Those decisions belong to qualified pathology and clinical teams.
Frequently asked questions
Are pathology slides returned after a consultation?
Return rules vary. Some borrowed slides or blocks may be returned, while material used for additional testing may be consumed. Confirm this in writing before release.
How long does pathology re-review take in China?
Timing depends on the hospital, appointment, material quality, and whether additional staining or molecular testing is required. SYSUCC publishes a 3–5 working day standard consultation example, but additional tests may extend it.
Can I upload digital slides myself?
Do not assume so. Publicly documented China workflows are often institution-to-institution. Ask the receiving hospital whether it accepts external WSI and through which channel.
Will digital pathology avoid the need to ship tissue?
It may allow a preliminary review to begin, but physical slides or blocks may still be needed.
Does an old biomarker result remain valid?
It may remain relevant, but recurrence, prior treatment, sample quality, and the current clinical question can affect whether repeat or additional testing is considered.
Can CareNavigator explain my pathology result?
CareNavigator can help organize the review pathway and questions. Medical interpretation must come from qualified pathologists and treating doctors.
If a China hospital has requested pathology materials, or you are unsure what to prepare, tell us your diagnosis, where the tissue is held, and what review you are seeking. CareNavigator can help coordinate the practical pathway before anything is shipped.
Related CareNavigator Resources
- Choosing a China Cancer Hospital: Checklist
- CAR-T Cell Therapy in China
- How CareNavigator Helps
- China Treatment Navigation Guide
- Tell Us Your Situation
Information note: Some practical details in this article draw on CareNavigator’s accumulated operational experience and publicly available information. Hospital pathways, service availability, travel rules, and other time-sensitive arrangements may change. Please refer to the latest official information from the relevant hospital, airline, or government authority before making plans.